Investor
Avego BioScience Capital
Alpharetta · United States
Avego BioScience Capital provides mid-to-late stage venture financing and growth capital for biotechnology and healthcare companies.
Stage
Series A–Growth
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
Digital Health
About
The firm operates as a multi-strategy investment firm specialising in the healthcare sector. It focuses on mid-to-late stage venture financings for biotech companies. The team employs an evidence-based approach to evaluate the scientific and medical qualities of products. They aim to unite industry expertise with management teams to improve the lives of patients. The firm invests its own capital, ensuring high alignment with company executives and other investment partners.
Recent deals
- 2026-07Memento MedicinesSeries A
- 2026-07Memento MedicinesSeries ALed
- 2026-02Alveus TherapeuticsSeries A
- 2026-01Alveus TherapeuticsSeries A
- 2026-01Alveus TherapeuticsSeries A
- 2026-01AlveusSeries A
- 2024-11TRexBioSeries B
- 2024-11TRexBioSeries B
- 2022-08AtomVie Global Radiopharma Inc.Series A
- 2022-08AtomVie Global Radiopharma Inc.Series A
- 2021-11Ellie DiagnosticsGrowth
- 2021-11Ellie DiagnosticsGrowth
- 2021-11Antios TherapeuticsSeries B
- 2021-11Antios TherapeuticsSeries B